WCN25-1101 ANTI-CD45 STAINING IN RENAL HISTOPATHOLOGY AS A PREDICTOR OF CLINICAL PRESENTATION AND SHORT-TERM OUTCOME IN LUPUS NEPHRITIS

WCN25-1101 ANTI-CD45 STAINING IN RENAL HISTOPATHOLOGY AS A PREDICTOR OF CLINICAL PRESENTATION AND SHORT-TERM OUTCOME IN LUPUS NEPHRITIS

Saved in:

Bibliographic Details
Main Authors:	Noureen Amin, Amit Bari, Muhammad Nazrul Islam, Muhammad Rafiqul Alam, Md. Rezwanur Rahman, Sadia Amin, Taiyeb Ibna Zahangir
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924023945
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Analysis of the Sensitivity and Specificity of Histopathological Findings for Diagnosing Lupus Nephritis
by: Epitácio Rafael da Luz Neto, et al.
Published: (2024-11-01)

Clinical and histopathological features of lupus nephritis and the risk of long-term kidney outcomes in Indonesia
by: Ni Made Hustrini, et al.
Published: (2025-06-01)

WCN25-4520 THE RELATIONSHIP BETWEEN PROTEINURIA, HEMATURIA, AND HISTOPATHOLOGICAL CHANGES IN LUPUS NEPHRITIS
by: Henrique Borges, et al.
Published: (2025-02-01)

WCN25-4595 CLINICOPATHOLOGICAL PATTERN AND OUTCOME OF PATIENTS WITH LUPUS NEPHRITIS: A SINGLE CENTRE STUDY AT BANGLADESH MEDICAL COLLEGE HOSPITAL
by: Sonia Mahjabin, et al.
Published: (2025-02-01)

WCN24-2084 CORRELATION BETWEEN CLINICAL, LABORATORY, AND HISTOPATHOLOGICAL FINDINGS IN PATIENTS DIAGNOSED WITH LUPUS NEPHRITIS
by: Maria Boglioli, et al.
Published: (2024-04-01)

WCN25-4491 LUPUS NEPHRITIS IN MALES: A COMPARATIVE ANALYSIS OF CLINICAL AND HISTOPATHOLOGICAL FEATURES WITH FEMALES
by: M. Prasanna, et al.
Published: (2025-02-01)

Disseminated Strongyloidiasis in a Patient With Lupus Nephritis
by: Muhammad Abu-Rmaileh, et al.
Published: (2023-09-01)

Prevalence and Associated Factors of Insomnia in Adult Psychiatric Patients: A Hospital-Based Study
by: Jhowhar Datta, et al.
Published: (2025-06-01)

The Evolution of Crescents in Lupus Nephritis
by: Ana Malvar, et al.
Published: (2025-05-01)

WCN25-1187 Clinical and Histopathological profile of lupus nephritis patients at tertiary care center in central India
by: Vandana Admane, et al.
Published: (2025-02-01)

Differential patterns of renal immunofluorescence staining for IgG subclass in membranous lupus nephritis infected with HBV and HBV associated membranous nephropathy
by: LU Jian-hua, et al.
Published: (2015-01-01)

WCN24-1455 NOT EVERYTHING IN LUPUS IS LUPUS NEPHRITIS
by: Enrique Fleuvier Morales López, et al.
Published: (2024-04-01)

Gender Differences in the Pathogenesis and Outcome of Lupus and of Lupus Nephritis
by: Julie Schwartzman-Morris, et al.
Published: (2012-01-01)

Dramatic Response of Lupus Enteritis, Nephritis, and Pancytopenia to Plasmapheresis and Rituximab
by: Adan Aftab, et al.
Published: (2022-01-01)

Prospects for the use of belimumab in lupus nephritis
by: N. L. Kozlovskaya, et al.
Published: (2021-08-01)

Evaluation of Treatment Response in Lupus Nephritis
by: Anca BOBIRCA, et al.
Published: (2021-12-01)

Recent advances in the treatment of lupus nephritis
by: Wan-xing Li, et al.
Published: (2022-08-01)

USE OF RITUXIMAB IN PATIENTS WITH LUPUS NEPHRITIS
by: Anna Vasilyevna Torgashina, et al.
Published: (2010-08-01)

Clinical application of belimumab in lupus nephritis
by: Zhou Han, et al.
Published: (2022-10-01)

The impacts of gender differences on systemic lupus erythematosus and lupus nephritis
by: LI Chun-hong, et al.
Published: (2019-01-01)

Immune Checkpoint Therapy–Induced Lupus Nephritis
by: Imran Humza Hanif, et al.
Published: (2024-05-01)

Lupus nephritis: What new is in morphological diagnosis?
by: S G Radenska-Lopovok
Published: (2008-08-01)

Lupus Nephritis: 10 questions to think about
by: Enrique Morales, et al.
Published: (2025-02-01)

Chemokines and Chemokine Receptors in the Development of Lupus Nephritis
by: Xiaofeng Liao, et al.
Published: (2016-01-01)

Lupus nephritis and thrombotic microangiopathy: A review
by: Larisa A. Bobrova, et al.
Published: (2024-01-01)

Prediction of prognosis and renal outcome in lupus nephritis
by: Farah Tamirou, et al.
Published: (2020-10-01)

MicroRNAs Implicated in the Immunopathogenesis of Lupus Nephritis
by: Cristen B. Chafin, et al.
Published: (2013-01-01)

Renal biopsy in lupus nephritis: To do or not to do?
by: Manish Rathi, et al.
Published: (2017-01-01)

Clinical significance of urine hepcidin in lupus nephritis
by: TANG Dai-rong, et al.
Published: (2017-01-01)

B cells and treatment progression in lupus nephritis
by: ZHANG Yue-qi, et al.
Published: (2019-01-01)

Research advances of the role of T lymphocytes in lupus nephritis
by: Zhang Ling-ge, et al.
Published: (2022-03-01)

Ras-MAPK pathway in patients with lupus nephritis
by: Dandan Liang, et al.
Published: (2025-03-01)

Decreased Expression of Aquaporins as a Feature of Tubular Damage in Lupus Nephritis
by: Maxime Melchior, et al.
Published: (2025-03-01)

P300 Enhances The Phosphorylation Of IRS-1 S1101 By P70 S6K-1
by: Vhuthuhawe Madzinge, et al.
Published: (2025-05-01)

Lupus nephritis as a specific clinical and immunological phenotype of systemic lupus erythematosus
by: E. A. Aseeva, et al.
Published: (2022-12-01)

WCN25-2968 CORRELATION OF SERUM ANTI-C1Q ANTIBODY WITH HISTOLOGICAL CHARACTERISTICS IN LUPUS NEPHRITIS
by: Sharmin Sultana, et al.
Published: (2025-02-01)

Lupus Nephritis in a Patient with Sickle Cell Disease
by: Vinay Minocha, et al.
Published: (2013-01-01)

Soluble Fas and the −670 Polymorphism of Fas in Lupus Nephritis
by: Juan José Bollain-y-Goytia, et al.
Published: (2014-01-01)

Correlation between dyslipidemia and disease activity of lupus nephritis
by: Hu Hong-tu, et al.
Published: (2021-01-01)

FDA approves belimumab for treatment of children with lupus nephritis
by: article Editorial
Published: (2022-10-01)